---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-015362"
form_type: "8-K"
ticker: "PAHC"
cik: "0001069899"
company_name: "PHIBRO ANIMAL HEALTH CORP"
filed_at: "2023-08-30T23:59:59+00:00"
generated_at: "2026-06-11T01:47:20.321670+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Phibro Q4 adj diluted EPS up 5% to $0.38; full-year net income down 34%

## Summary
- Q4 net sales $255.0M (flat YoY); net income $11.5M (+54%); adj diluted EPS $0.38 (+5%).
- FY2023 net sales $977.9M (+4%); net income $32.6M (-34%); adj diluted EPS $1.21 (-8%).
- FY2024 guidance: net sales $1.0-1.05B; adj EBITDA $115-121M; adj diluted EPS $1.12-1.27.
- Animal Health FY sales +9% to $659.9M; Mineral Nutrition -6%; gross leverage 4.2x.
- Free cash flow negative $24M; liquidity $248M; pension settlement to incur ~$10.4M expense in Q1 FY2024.

## SEC filing metadata
- accession: 0001558370-23-015362
- form_type: 8-K
- ticker: PAHC
- cik: 0001069899
- company_name: PHIBRO ANIMAL HEALTH CORP
- filed_at: 2023-08-30T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1069899/000155837023015362/0001558370-23-015362-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1069899/000155837023015362/pahc-20230830x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-015362
- JSON: https://secwatch.observer/filing/0001558370-23-015362.json
- Plain text: https://secwatch.observer/filing/0001558370-23-015362.txt

## Key facts
- Earnings Releases
  PHIBRO ANIMAL HEALTH CORP updated its the fiscal quarter and fiscal year ended June 30, 2023 guidance (initiated).
  - Period: the fiscal quarter and fiscal year ended June 30, 2023
  - Guidance: initiated
  - Result: reported results
  source text: Phibro Animal Health Corporation issued a press release announcing its operating results for the fiscal quarter and fiscal year ended June 30, 2023 and its financial guidance for the fiscal year ending June 30, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1069899/000155837023015362/0001558370-23-015362-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.